District Judge Karen Spencer Marston has scheduled the Science Day for MDL 3163 (Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation) for June 2, 2026
Clinical efficacy data is from FDA-approved branded GLP-1 medications (Mounjaro, Zepbound, Wegovy, Ozempic)
Together, lets embark on this wellness journey, ensuring that each step we take is informed, empowering, and aligned with our health goals.
D.GasbarriniA.et al (2019)
They can suggest a cellulite treatment that can be most effective for you.
On rare occasions when needed, they still created individualized concoctions but the number of prescriptions that required some kind of compounding dropped from 75% in the 1930s to less than 5% by 1960